Get started
Keyword

ROP recurrence

Description: The return of retinopathy of prematurity after it has regressed or been treated, considered in clinical follow-up.
OpenAlex ID: keywords/rop-recurrence
Reactivation of Retinopathy of Prematurity After Bevacizumab Injection
2012 · Jennifer Hu, Michael P. Blair, et al. · Archives of Ophthalmology · 304
Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity
2018 · Andreas Stahl, Tim U. Krohne, et al. · Archives of Pediatrics and Adolescent Medicine · 156
PDF
Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity
2017 · Deborah K. VanderVeen, Michele Melia, et al. · Ophthalmology · 148
PDF
Intravitreal Anti-vascular Endothelial Growth Factor Treatment for Retinopathy of Prematurity
2014 · San-Ni Chen, Iebin Lian, et al. · Retina · 123
A Dosing Study of Bevacizumab for Retinopathy of Prematurity
2018 · David K. Wallace, Trevano W. Dean, et al. · Ophthalmology · 113
Comparison of Intravitreal Injection of Ranibizumab Versus Laser Therapy for Zone Ii Treatment-requiring Retinopathy of Prematurity
2016 · Guoming Zhang, Mingmin Yang, et al. · Retina · 103
Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey
2016 · Murat Gunay, Emine Alyamac Sukgen, et al. · Current Eye Research · 90
Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity
2016 · Brian C. Toy, Ira H. Schachar, et al. · Ophthalmology · 89
Structural, Visual and Refractive Outcomes of Intravitreal Aflibercept Injection in High-Risk Prethreshold Type 1 Retinopathy of Prematurity
2014 · Abdelrahman G. Salman, Aza M. Said · Ophthalmic Research · 71
Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity
2018 · Emine Alyamaç Sukgen, Yusuf Koçluk · Graefe s Archive for Clinical and Experimental Ophthalmology · 68
Rates and Risk Factors for Recurrence of Retinopathy of Prematurity After Laser or Intravitreal Anti–vascular Endothelial Growth Factor Monotherapy
2019 · Kiet-Phang Ling, Pei-Ju Liao, et al. · Retina · 67
Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone
2016 · B Mueller, D J Salchow, et al. · British Journal of Ophthalmology · 63
Efficacy of intravitreal bevacizumab for zone‐ II retinopathy of prematurity
2016 · Reza Karkhaneh, Alireza Khodabande, et al. · Acta Ophthalmologica · 59
PDF
Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children
2017 · Emrah Utku Kabataş, Bengi Ece Kurtul, et al. · Current Eye Research · 49
Short-term Outcomes After Intravitreal Injections of Conbercept Versus Ranibizumab for the Treatment of Retinopathy of Prematurity
2017 · Enzhong Jin, Hong Yin, et al. · Retina · 45
Efficacy of intravitreal conbercept injection in the treatment of retinopathy of prematurity
2018 · Yichen Bai, Huanjie Nie, et al. · British Journal of Ophthalmology · 42
Management of Retinopathy of Prematurity—Use of Anti-VEGF Therapy
2017 · Tran, Kimberly D., Cernichiaro-Espinosa, Linda A., et al. · Asia-Pacific Journal of Ophthalmology · 41
The German ROP Registry: data from 90 infants treated for retinopathy of prematurity
2016 · Johanna M. Walz, Sebastian Bemme, et al. · Acta Ophthalmologica · 41
PDF
Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial
2021 · Zhenquan Wu, Jinfeng Zhao, et al. · British Journal of Ophthalmology · 40
PDF
Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes
2018 · Hyun Goo Kang, Eun Young Choi, et al. · Korean Journal of Ophthalmology · 40
Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity
2020 · Yong Cheng, Xuemei Zhu, et al. · Acta Ophthalmologica · 38
PDF
Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity
2014 · Sarah Moran, Michael O'Keefe, et al. · Acta Ophthalmologica · 37
Complications of retinopathy of prematurity treatment
2021 · Joshua M. Barnett, G. Baker Hubbard · Current Opinion in Ophthalmology · 35
Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study
2017 · Qinrui Hu, Yujing Bai, et al. · Journal of Ophthalmology · 33
PDF
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity
2024 · Andreas Stahl, Hidehiko Nakanishi, et al. · JAMA Network Open · 30
Works count: 140
Citation count: 2,439
Year
Topic
Type